Log In
BCIQ
Print this Print this
 

IGSC, 20% subcutaneous immunoglobulin (Cuvitru)

Also known as: Immune globulin 20%

  Manage Alerts
Collapse Summary General Information
Company Shire plc
Description20% subcutaneous immunoglobulin
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentMarketed
Standard IndicationImmunodeficiency
Indication DetailsTreat primary immunodeficiencies
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today